Author

Hugh Nymeyer

Observed name: H. Nymeyer

Institution: University of Arkansas for Medical Sciences

Observed institutions: University of New Mexico Hospital, University of Arkansas Medical Center, Baptist Health Foundation, University of Arkansas for Medical Sciences, The University of Texas Southwestern Medical Center

OpenAlex ID: A5077390750

Changes in Disease Activity and Damage Over Time in Patients With Morphea

2020 · Jack C. O’Brien, Hugh Nymeyer, et al. · JAMA Dermatology · 35

Preliminary results from a phase I study of substance P-saporin in terminal cancer patients with intractable pain.

2014 · Arthur E. Frankel, Hugh Nymeyer, et al. · Journal of Clinical Oncology · 6

Substance P–Saporin for the Treatment of Intractable Pain

2017 · Hugh Nymeyer, Douglas A. Lappi, et al. · Milestones in drug therapy · 3

Cutaneous Ulcers Secondary to Cytomegalovirus and Herpes Simplex Virus in an Immunocompromised Patient

2016 · D. Winslow Blankenship, Hugh Nymeyer, et al. · The American Journal of the Medical Sciences · 2

Intrathecal Substance P-Saporin for the Treatment of Intractable Cancer Pain

2016 · Hugh Nymeyer, Douglas A. Lappi, et al. · Springer eBooks · 1

Multiple Hyperpigmented Lesions in a Young Girl

2023 · Katie Dreher, Jonathan W. Rick, et al. · Pediatrics in Review

Erythematous Plaques and Tense Bullae in an Infant

2021 · Amanda Ederle, Cees T Whisonant, et al. · Cureus

16709 Pyoderma gangrenosum: A report on clinical experiences of 22 cases treated at a tertiary referral center

2020 · Hugh Nymeyer, Henry K. Wong · Journal of the American Academy of Dermatology

479 A retrospective review of 23 cases of pyoderma gangrenosum: Effects of comorbid conditions on treatment response

2020 · H. Nymeyer, H.K. Wong · Journal of Investigative Dermatology

Works count: 9

Citation count: 47

H-index: 3

I10-index: 1